Objective: To investigate the efficacy and safety of NovaSure system for dysmenorrhea and abnormal uterine bleeding of adenomyosis.
Methods: A retrospective analysis on 30 patients with adenomyosis, who treated by NovaSure, were carried out. We collected related clinical data before operation and collected postoperative information about dyemenorrhea, menstruation, anemia and uterine volume by visiting outpatient or telephone.
Results: All patients were followed up for 7 to 31 months after the operation. The relief rate of menstrual pain was 83.3%. All patients got obvious improvements in menstruation and anemia (P<0.05). After operation, uterine volume was significantly decreased (P<0.05). Only one case received intervention in 2 years (3.3%).
Conclusion: NovaSure can relieve symptoms of menorrhagia and alleviate dysmenorrhea symptoms. It is a new way for the treatment of uterine adenomyosis.
目的：探讨诺舒(NovaSure)子宫内膜去除术治疗子宫腺肌病痛经合并月经过多的临床疗效及安全性。 方法：对30例行诺舒治疗的子宫腺肌病痛经合并月经过多患者的临床资料进行回顾性分析，收集病例相关资料，通过门诊复诊或电话随访术后痛经、月经及贫血改善情况，比较手术前后B超子宫体积。结果：随访7~31个月，诺舒术后痛经缓解有效率83.3%，月经改善率为100%，贫血症状均明显好转，术后血红蛋白值比术前明显升高，差异有统计学意义(P<0.05)。术后子宫体积较术前缩小，差异有统计学意义(P<0.05)。术后2年内再次干预治疗1例(3.3%)。结论：诺舒用于治疗子宫腺肌病，既能解除月经过多症状又能使痛经症状明显缓解，是一种治疗子宫腺肌病的新方式。.